The nation of Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on sensitive information.
This move came to light after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson later explained that the United States was seeking genetic material for scientific study and commercial gain while was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more talks to find a deal agreeable to all parties so the nation's vital HIV programme can proceed.
Wider Context
This development follows a comparable situation in Kenya, where a high court suspended a related deal with the US after concerns were filed about the security of citizens' health data.
Since returning to office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," his statement read.
"In essence, our country would provide the basic resources for medical research without any certainty that the final treatments would be available to our population should a future health crisis emerge."
National Interest and Global Health
He also said that the American exit from the global health body and its push of one-on-one health agreements were upending structures already established via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it understood the government's concerns, but suggested that negotiations need to persist since a large portion of the nation's HIV programmes relied on external financing.
"If technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group added.
The situation highlights the continuing debate between accepting crucial foreign assistance and protecting local interests in an ever more interconnected world.